Omics-Based Clinical Trials Market Size, Share, By Phase Type (Phase I, Phase II, Phase III, and Phase IV), By Study Design Type (Interventional Studies, Observational Studies, and Expanded Access Studies), By Indication Type (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases, and Others), and By Region - Trends, Analysis and Forecast till 2034

Drug Repurposing and Combination Therapies:

• Omics-based research can foster drug repurposing by defining new indications for known drugs. Another aspect is the definition of potential drug combinations, based on molecular mechanisms of the disease, for situations when single agents are not very effective. In this regard, the strategies can cut down the time consumed in the development of drugs, provide better outcomes for the patients, and reduce the chance of failure at the clinical trial stage.